【2176】イナリサーチ
〔上場廃止〕
ー(上場廃止)医薬品の非臨床試験。
類似企業:
【業界1位】
H.U.グループホールディングス
【業界1位】
H.U.グループホールディングス
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023.03 | 2022/08/10 | Q1予 | 4,328 | → | 0.0% | 0.0% | 373 | → | 0.0% | 0.0% | 350 | → | 0.0% | 0.0% | 298 | → | 0.0% | 0.0% |
2023.03 | 2022/05/12 | 当初予 | 4,328 | - | - | - | 373 | - | - | - | 350 | - | - | - | 298 | - | - | - |
2022.03 | 2022/05/12 | 実 | 3,204 | → | 0.0% | +0.1% | 351 | ↑ | +3.8% | +132.5% | 339 | ↑ | +0.6% | +173.4% | 334 | ↓ | -1.5% | +215.1% |
2022.03 | 2022/04/15 | 修正予 | 3,204 | ↓ | -2.3% | +0.1% | 338 | ↑ | +38.0% | +123.8% | 337 | ↑ | +47.8% | +171.8% | 339 | ↑ | +77.5% | +219.8% |
2022.03 | 2022/02/10 | Q3予 | 3,278 | → | 0.0% | +2.4% | 245 | → | 0.0% | +62.3% | 228 | → | 0.0% | +83.9% | 191 | → | 0.0% | +80.2% |
2022.03 | 2022/01/27 | 修正予 | 3,278 | → | 0.0% | +2.4% | 245 | ↑ | +7.5% | +62.3% | 228 | ↑ | +16.9% | +83.9% | 191 | ↑ | +19.4% | +80.2% |
2022.03 | 2021/11/11 | Q2予 | 3,278 | → | 0.0% | +2.4% | 228 | → | 0.0% | +51.0% | 195 | → | 0.0% | +57.3% | 160 | → | 0.0% | +50.9% |
2022.03 | 2021/10/27 | 修正予 | 3,278 | ↑ | +2.4% | +2.4% | 228 | ↑ | +51.0% | +51.0% | 195 | ↑ | +57.3% | +57.3% | 160 | ↑ | +50.9% | +50.9% |
2022.03 | 2021/08/05 | Q1予 | 3,200 | → | 0.0% | 0.0% | 151 | → | 0.0% | 0.0% | 124 | → | 0.0% | 0.0% | 106 | → | 0.0% | 0.0% |
2022.03 | 2021/05/13 | 当初予 | 3,200 | - | - | - | 151 | - | - | - | 124 | - | - | - | 106 | - | - | - |
2021.03 | 2021/05/13 | 実 | 2,929 | → | 0.0% | -9.9% | 205 | ↑ | +169.7% | +169.7% | 177 | → | 0.0% | +268.8% | 232 | → | 0.0% | +510.5% |
2021.03 | 2021/05/10 | 修正予 | 2,929 | ↓ | -9.9% | -9.9% | - | - | - | - | 177 | ↑ | +268.8% | +268.8% | 232 | ↑ | +510.5% | +510.5% |
2021.03 | 2021/02/10 | Q3予 | 3,250 | → | 0.0% | 0.0% | 76 | → | 0.0% | 0.0% | 48 | → | 0.0% | 0.0% | 38 | → | 0.0% | 0.0% |
2021.03 | 2020/11/06 | Q2予 | 3,250 | → | 0.0% | 0.0% | 76 | → | 0.0% | 0.0% | 48 | → | 0.0% | 0.0% | 38 | → | 0.0% | 0.0% |
2021.03 | 2020/08/06 | Q1予 | 3,250 | → | 0.0% | 0.0% | 76 | → | 0.0% | 0.0% | 48 | → | 0.0% | 0.0% | 38 | → | 0.0% | 0.0% |
2021.03 | 2020/05/13 | 当初予 | 3,250 | - | - | - | 76 | - | - | - | 48 | - | - | - | 38 | - | - | - |
2020.03 | 2020/05/13 | 実 | 2,862 | ↓ | -4.5% | -4.5% | 61 | ↓ | -41.3% | -41.3% | 30 | ↓ | -60.0% | -60.0% | 36 | ↓ | -42.9% | -42.9% |
2020.03 | 2020/02/13 | Q3予 | 2,996 | → | 0.0% | 0.0% | 104 | → | 0.0% | 0.0% | 75 | → | 0.0% | 0.0% | 63 | → | 0.0% | 0.0% |
2020.03 | 2019/11/13 | Q2予 | 2,996 | → | 0.0% | 0.0% | 104 | → | 0.0% | 0.0% | 75 | → | 0.0% | 0.0% | 63 | → | 0.0% | 0.0% |
2020.03 | 2019/08/09 | Q1予 | 2,996 | → | 0.0% | 0.0% | 104 | → | 0.0% | 0.0% | 75 | → | 0.0% | 0.0% | 63 | → | 0.0% | 0.0% |
2020.03 | 2019/05/14 | 当初予 | 2,996 | - | - | - | 104 | - | - | - | 75 | - | - | - | 63 | - | - | - |
2019.03 | 2019/05/14 | 実 | 2,585 | ↓ | -6.9% | -6.9% | 93 | ↓ | -21.2% | -20.5% | 60 | ↓ | -24.1% | -23.1% | 56 | ↓ | -16.4% | -15.2% |
2019.03 | 2019/02/13 | Q3予 | 2,778 | → | 0.0% | 0.0% | 118 | → | 0.0% | +0.9% | 79 | → | 0.0% | +1.3% | 67 | → | 0.0% | +1.5% |
2019.03 | 2018/11/12 | Q2予 | 2,778 | → | 0.0% | 0.0% | 118 | → | 0.0% | +0.9% | 79 | → | 0.0% | +1.3% | 67 | → | 0.0% | +1.5% |
2019.03 | 2018/08/10 | Q1予 | 2,778 | → | 0.0% | 0.0% | 118 | ↑ | +0.9% | +0.9% | 79 | ↑ | +1.3% | +1.3% | 67 | ↑ | +1.5% | +1.5% |
2019.03 | 2018/05/14 | 当初予 | 2,778 | - | - | - | 117 | - | - | - | 78 | - | - | - | 66 | - | - | - |
2018.03 | 2018/05/14 | 実 | 2,425 | ↑ | +5.4% | +5.4% | 196 | ↑ | +148.1% | +148.1% | 156 | ↑ | +1460.0% | +1460.0% | 141 | ↑ | +2250.0% | +2250.0% |
2018.03 | 2018/02/13 | Q3予 | 2,300 | → | 0.0% | 0.0% | 79 | → | 0.0% | 0.0% | 10 | → | 0.0% | 0.0% | 6 | → | 0.0% | 0.0% |
2018.03 | 2017/11/13 | Q2予 | 2,300 | → | 0.0% | 0.0% | 79 | → | 0.0% | 0.0% | 10 | → | 0.0% | 0.0% | 6 | → | 0.0% | 0.0% |
2018.03 | 2017/08/10 | Q1予 | 2,300 | - | - | - | 79 | - | - | - | 10 | - | - | - | 6 | - | - | - |
2017.03 | 2017/05/12 | 修正予 | 2,295 | ↓ | -2.0% | -2.0% | 56 | ↑ | +19.1% | +19.1% | 23 | ↑ | +155.6% | +155.6% | 31 | ↑ | - | - |
2017.03 | 2017/02/14 | Q3予 | 2,342 | → | 0.0% | 0.0% | 47 | → | 0.0% | 0.0% | 9 | → | 0.0% | 0.0% | 0 | → | - | - |
2017.03 | 2016/11/14 | Q2予 | 2,342 | → | 0.0% | 0.0% | 47 | → | 0.0% | 0.0% | 9 | → | 0.0% | 0.0% | 0 | → | - | - |
2017.03 | 2016/08/12 | Q1予 | 2,342 | - | - | - | 47 | - | - | - | 9 | - | - | - | 0 | - | - | - |
2016.03 | 2016/05/13 | 修正予 | 2,116 | ↑ | +0.3% | -5.1% | -207 | ↑ | +38.0% | -592.9% | -230 | ↑ | +35.6% | -1869.2% | -1,204 | ↓ | -57.4% | -17300.0% |
2016.03 | 2016/02/12 | Q3予 | 2,110 | → | 0.0% | -5.4% | -334 | → | 0.0% | -895.2% | -357 | → | 0.0% | -2846.2% | -765 | → | 0.0% | -11028.6% |
2016.03 | 2015/11/13 | Q2予 | 2,110 | → | 0.0% | -5.4% | -334 | → | 0.0% | -895.2% | -357 | → | 0.0% | -2846.2% | -765 | → | 0.0% | -11028.6% |
2016.03 | 2015/11/02 | 修正予 | 2,110 | ↓ | -5.4% | -5.4% | -334 | ↓ | -895.2% | -895.2% | -357 | ↓ | -2846.2% | -2846.2% | -765 | ↓ | -11028.6% | -11028.6% |
2016.03 | 2015/08/14 | Q1予 | 2,230 | → | 0.0% | 0.0% | 42 | - | - | - | 13 | → | 0.0% | 0.0% | 7 | → | 0.0% | 0.0% |
2016.03 | 2015/05/15 | 当初予 | 2,230 | - | - | - | - | - | - | - | 13 | - | - | - | 7 | - | - | - |
2015.03 | 2015/05/15 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
2015.03 | 2015/02/10 | Q3予 | 3,000 | → | 0.0% | 0.0% | 83 | → | 0.0% | 0.0% | 50 | → | 0.0% | 0.0% | 28 | → | 0.0% | 0.0% |
2015.03 | 2014/11/11 | Q2予 | 3,000 | → | 0.0% | 0.0% | 83 | → | 0.0% | 0.0% | 50 | → | 0.0% | 0.0% | 28 | → | 0.0% | 0.0% |
2015.03 | 2014/08/12 | Q1予 | 3,000 | → | 0.0% | 0.0% | 83 | → | 0.0% | 0.0% | 50 | → | 0.0% | 0.0% | 28 | → | 0.0% | 0.0% |
2015.03 | 2014/05/13 | 当初予 | 3,000 | - | - | - | 83 | - | - | - | 50 | - | - | - | 28 | - | - | - |
2014.03 | 2014/05/13 | 実 | 2,778 | → | 0.0% | 0.0% | 66 | → | 0.0% | 0.0% | 49 | → | 0.0% | 0.0% | 70 | → | 0.0% | 0.0% |
2014.03 | 2014/05/07 | 当初予 | 2,778 | - | - | - | 66 | - | - | - | 49 | - | - | - | 70 | - | - | - |